首页> 外文期刊>Human Molecular Genetics >α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
【24h】

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

机译:α-突触核蛋白在细胞核中起作用以抑制组蛋白乙酰化并促进神经毒性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

α-synuclein is a neuronal protein implicated genetically in Parkinson's disease. α-synuclein localizes to the nucleus and presynaptic nerve terminals. Here we show that α-synuclein mediates neurotoxicity in the nucleus. Targeting of α-synuclein to the nucleus promotes toxicity, whereas cytoplasmic sequestration is protective in both cell culture and transgenic Drosophila. Toxicity of α-synuclein can be rescued by administration of histone deacetylase inhibitors in both cell culture and transgenic flies. α-synuclein binds directly to histones, reduces the level of acetylated histone H3 in cultured cells and inhibits acetylation in histone acetyltransferase assays. α-synuclein mutations that cause familial Parkinson's disease, A30P and A53T, exhibit increased nuclear targeting in cell culture. These findings implicate nuclear α-synuclein in promoting nigrostriatal degeneration in Parkinson's disease and encourage exploration of histone deacetylase inhibitors as potential therapies for the disorder.
机译:α-突触核蛋白是遗传上与帕金森氏病有关的神经元蛋白。 α-突触核蛋白位于细胞核和突触前神经末梢。在这里,我们显示α-突触核蛋白介导细胞核中的神经毒性。将α-突触核蛋白靶向细胞核可促进毒性,而细胞质螯合在细胞培养和转基因果蝇中均具有保护作用。可以通过在细胞培养和转基因果蝇中施用组蛋白脱乙酰基酶抑制剂来挽救α-突触核蛋白的毒性。 α-突触核蛋白直接与组蛋白结合,在培养的细胞中降低乙酰化组蛋白H3的水平,并在组蛋白乙酰转移酶测定中抑制乙酰化。导致家族性帕金森氏病(A30P和A53T)的α-突触核蛋白突变在细胞培养中显示出增加的核靶向性。这些发现暗示核α-突触核蛋白促进帕金森氏病的黑质纹状体变性,并鼓励探索组蛋白脱乙酰基酶抑制剂作为该疾病的潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号